NVZMY vs. DSV.CO

Last updated Apr 2, 2026

Compare and contrast key facts about Novozymes AS (NVZMY) and DSV A/S (DSV.CO).

Performance

NVZMY vs. DSV.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novozymes AS (NVZMY) and DSV A/S (DSV.CO). The values are adjusted to include any dividend payments, if applicable.

NVZMY vs. DSV.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NVZMY Novozymes AS	-4.43%	14.29%	3.97%	12.42%	-38.46%	46.93%	18.10%	10.28%	-20.91%	69.59%
DSV.CO DSV A/S	-3.44%	19.70%	22.01%	12.10%	-32.08%	38.78%	47.18%	75.27%	-16.01%	77.88%

Different Trading Currencies

NVZMY is traded in USD, while DSV.CO is traded in DKK. To make them comparable, the DSV.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, NVZMY achieves a -4.43% return, which is significantly lower than DSV.CO's -3.44% return. Over the past 10 years, NVZMY has underperformed DSV.CO with an annualized return of 4.60%, while DSV.CO has yielded a comparatively higher 19.85% annualized return.

NVZMY

• 1D: 0.53%
• 1M: 4.83%
• YTD: -4.43%
• 6M: -1.80%
• 1Y: 5.95%
• 3Y*: 7.39%
• 5Y*: 0.29%
• 10Y*: 4.60%

DSV.CO

• 1D: 3.18%
• 1M: -4.46%
• YTD: -3.44%
• 6M: 21.57%
• 1Y: 24.58%
• 3Y*: 8.71%
• 5Y*: 4.95%
• 10Y*: 19.85%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NVZMY vs. DSV.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVZMY

NVZMY Risk / Return Rank: 44
NVZMY Sharpe Ratio Rank: 48
NVZMY Sortino Ratio Rank: 41
NVZMY Omega Ratio Rank: 41
NVZMY Calmar Ratio Rank: 45
NVZMY Martin Ratio Rank: 45

DSV.CO

DSV.CO Risk / Return Rank: 55
DSV.CO Sharpe Ratio Rank: 58
DSV.CO Sortino Ratio Rank: 51
DSV.CO Omega Ratio Rank: 52
DSV.CO Calmar Ratio Rank: 58
DSV.CO Martin Ratio Rank: 56

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVZMY vs. DSV.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novozymes AS (NVZMY) and DSV A/S (DSV.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVZMY	DSV.CO	Difference
Sharpe ratio Return per unit of total volatility	0.22	0.70	-0.48
Sortino ratio Return per unit of downside risk	0.51	1.16	-0.65
Omega ratio Gain probability vs. loss probability	1.06	1.16	-0.09
Calmar ratio Return relative to maximum drawdown	0.19	1.09	-0.90
Martin ratio Return relative to average drawdown	0.38	2.32	-1.94
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVZMY vs. DSV.CO - Sharpe Ratio Comparison

The current NVZMY Sharpe Ratio is 0.22, which is lower than the DSV.CO Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of NVZMY and DSV.CO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NVZMY	DSV.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.22	0.70	-0.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.01	0.15	-0.14
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.17	0.66	-0.49
Sharpe Ratio (All Time) Calculated using the full available price history	-0.07	0.44	-0.52

Correlation

The correlation between NVZMY and DSV.CO is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NVZMY vs. DSV.CO - Dividend Comparison

NVZMY's dividend yield for the trailing twelve months is around 2.71%, more than DSV.CO's 0.44% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVZMY Novozymes AS	2.71%	1.51%	1.03%	2.68%	1.68%	0.69%	0.91%	1.03%	1.10%	1.64%	0.95%	0.60%
DSV.CO DSV A/S	0.44%	0.43%	0.46%	0.55%	0.50%	0.26%	0.25%	0.29%	0.47%	0.37%	0.54%	0.59%

Drawdowns

NVZMY vs. DSV.CO - Drawdown Comparison

The maximum NVZMY drawdown since its inception was -86.29%, which is greater than DSV.CO's maximum drawdown of -76.28%. Use the drawdown chart below to compare losses from any high point for NVZMY and DSV.CO.

Drawdown Indicators

	NVZMY	DSV.CO	Difference
Max Drawdown Largest peak-to-trough decline	-86.29%	-73.37%	-12.92%
Max Drawdown (1Y) Largest decline over 1 year	-29.64%	-22.33%	-7.31%
Max Drawdown (5Y) Largest decline over 5 years	-51.86%	-48.05%	-3.81%
Max Drawdown (10Y) Largest decline over 10 years	-51.86%	-48.05%	-3.81%
Current Drawdown Current decline from peak	-58.86%	-16.79%	-42.07%
Average Drawdown Average peak-to-trough decline	-57.40%	-13.16%	-44.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.99%	11.45%	+3.54%

Volatility

NVZMY vs. DSV.CO - Volatility Comparison

The current volatility for Novozymes AS (NVZMY) is 8.01%, while DSV A/S (DSV.CO) has a volatility of 10.35%. This indicates that NVZMY experiences smaller price fluctuations and is considered to be less risky than DSV.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVZMY	DSV.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.01%	10.35%	-2.34%
Volatility (6M) Calculated over the trailing 6-month period	18.93%	23.32%	-4.39%
Volatility (1Y) Calculated over the trailing 1-year period	27.15%	35.73%	-8.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.79%	32.43%	-4.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.20%	30.22%	-3.02%

Financials